These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7644063)

  • 21. [Effects of the "drug holiday" on problems of long-term levodopa therapy against Parkinson's disease].
    Mizuno Y; Joshita Y; Yoshida M; Kaneko J; Tanaka Y; Nagatsuka Y
    Nihon Naika Gakkai Zasshi; 1984 Apr; 73(4):474-80. PubMed ID: 6470552
    [No Abstract]   [Full Text] [Related]  

  • 22. Loss of long-duration response to levodopa over time in PD: implications for wearing-off.
    Zappia M; Oliveri RL; Montesanti R; Rizzo M; Bosco D; Plastino M; Crescibene L; Bastone L; Aguglia U; Gambardella A; Quattrone A
    Neurology; 1999 Mar; 52(4):763-7. PubMed ID: 10078724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of acute levodopa withdrawal on motor performance and dopaminergic receptor sensitivity in patients with Parkinson's disease.
    Turjanski N; Fernandez W; Lees AJ
    J Neurol Neurosurg Psychiatry; 1993 Jul; 56(7):771-5. PubMed ID: 8331352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-response relationship of levodopa with mood and anxiety in fluctuating Parkinson's disease: a double-blind, placebo-controlled study.
    Maricle RA; Nutt JG; Valentine RJ; Carter JH
    Neurology; 1995 Sep; 45(9):1757-60. PubMed ID: 7675241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does levodopa slow or hasten the rate of progression of Parkinson's disease?
    Fahn S;
    J Neurol; 2005 Oct; 252 Suppl 4():IV37-IV42. PubMed ID: 16222436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, Part I.
    Fabbrini G; Mouradian MM; Juncos JL; Schlegel J; Mohr E; Chase TN
    Ann Neurol; 1988 Sep; 24(3):366-71. PubMed ID: 3228270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Motor response to levodopa in patients with parkinsonian motor fluctuations: a follow-up study over three years.
    Hughes AJ; Frankel JP; Kempster PA; Stern GM; Lees AJ
    J Neurol Neurosurg Psychiatry; 1994 Apr; 57(4):430-4. PubMed ID: 8163991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Motor complications in patients with Parkinson disease treated with levodopa].
    Luquin MR; Obeso JA; Martínez-Lage JM
    Neurologia; 1989; 4(1):4-11. PubMed ID: 2631806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 'Drug holidays' in the treatment of Parkinson's disease. A brief review.
    Friedman JH
    Arch Intern Med; 1985 May; 145(5):913-5. PubMed ID: 3888135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age influences magnitude but not duration of response to levodopa.
    Durso R; Isaac K; Perry L; Saint-Hilaire M; Feldman RG
    J Neurol Neurosurg Psychiatry; 1993 Jan; 56(1):65-8. PubMed ID: 8429325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does an inhibitory action of levodopa contribute to motor fluctuations?
    Nutt JG; Gancher ST; Woodward WR
    Neurology; 1988 Oct; 38(10):1553-7. PubMed ID: 3419597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rate of motor response to oral levodopa and the clinical progression of Parkinson's disease.
    Contin M; Riva R; Martinelli P; Triggs EJ; Albani F; Baruzzi A
    Neurology; 1996 Apr; 46(4):1055-8. PubMed ID: 8780090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of L-dopa holiday in the long-term management of Parkinson's disease.
    Kaye JA; Feldman RG
    Clin Neuropharmacol; 1986; 9(1):1-13. PubMed ID: 3548951
    [No Abstract]   [Full Text] [Related]  

  • 34. Nighttime levodopa infusions to treat motor fluctuations in advanced Parkinson's disease: preliminary observations.
    Sage JI; Mark MH
    Ann Neurol; 1991 Oct; 30(4):616-7. PubMed ID: 1789688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Locomotor response to levodopa in fluctuating Parkinson's disease.
    Moore ST; MacDougall HG; Gracies JM; Ondo WG
    Exp Brain Res; 2008 Feb; 184(4):469-78. PubMed ID: 17828529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The results of drug holiday in Parkinson's disease].
    Martínez F; Castillo J; Castro A; Lema M; Noya M
    Neurologia; 1992 Nov; 7(9):254-9. PubMed ID: 1445710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Motor response to acute dopaminergic challenge with apomorphine and levodopa in Parkinson's disease: implications for the pathogenesis of the on-off phenomenon.
    Colosimo C; Merello M; Hughes AJ; Sieradzan K; Lees AJ
    J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):634-7. PubMed ID: 8648329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bromocriptine: long-term low-dose therapy in Parkinson's disease.
    Teychenne PF; Bergsrud D; Elton RL; Racy A
    Clin Neuropharmacol; 1986; 9(2):138-45. PubMed ID: 3708599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levodopa pharmacokinetic mechanisms and motor fluctuations in Parkinson's disease.
    Fabbrini G; Juncos J; Mouradian MM; Serrati C; Chase TN
    Ann Neurol; 1987 Apr; 21(4):370-6. PubMed ID: 3579222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-acting carbidopa-levodopa in the management of moderate and advanced Parkinson's disease.
    Hutton JT; Morris JL
    Neurology; 1992 Jan; 42(1 Suppl 1):51-6; discussion 57-60. PubMed ID: 1549202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.